Evaluating short-term dual antiplatelet therapy after a specific heart stent implantation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the efficacy and safety of a short duration of dual antiplatelet therapy (DAPT) following the implantation of the GENOSS® drug-eluting stent in patients with coronary artery disease. The study will collect real-world clinical outcomes data from six sites in South Korea, focusing on a device-oriented composite endpoint and a patient-oriented composite endpoint over a 12-month period. Participants will be monitored for cardiac events and revascularization needs to determine the optimal duration of DAPT after stent placement.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients of 19 and over
2. Patients with coronary artery disease treated with GENOSS SES
3. Participants who voluntarily decide to participate in this clinical trial, agree to the study protocol and clinical follow-up plan, and provide written informed consent as study participants

Exclusion Criteria:

1. Patients with cardiogenic shock at the time of hospitalization
2. Patients who are pregnant or planning to become pregnant
3. Patients with a life expectancy of less than 1 year
4. Patients participating in randomized controlled trials using other medical devices
5. Patients who have already received treatment with another DES (Drug Eluting Stent) or BMS (Bare Metal Stent) at the time of registration (However, other stent insertions are allowed due to failure of GENOSS DES insertion)

Where it's running

• Wonju Severance Christian Hospital
  Wŏnju, Gangwon State, South Korea Recruiting

Study contacts

• Study coordinator: YoungJin Youn
• Email: younyj@yonsei.ac.kr
• Phone: 033-741-0910

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating 1-year Dual Antiplatelet Therapy after GENOSS® Stent Implantation in Heart Disease Patients

  This study is testing whether a year of dual antiplatelet therapy after getting a GENOSS® stent helps heart disease patients stay healthy and avoid serious heart problems.

  Recruiting Genoss Co., Ltd. · Wŏnju, Gangwon State · NCT06075433

• Pilates breathing vs diaphragmatic breathing after PCI

  This study tests whether Pilates breathing or diaphragmatic breathing helps improve oxygen levels and heart-rate variability in people who just had PCI.

  Recruiting Foundation University Islamabad · Rawalpindi · NCT07872098

• Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI

  This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.

  Recruiting Jilin University · Changchun, Jilin · NCT07846462

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Dual antihypertensive combinations after PCI: ARB + thiazide versus ARB + amlodipine

  This trial tests two blood pressure treatment combos after a stent procedure in people with hypertension and coronary disease to see which regimen better controls blood pressure and improves symptoms.

  Recruiting National Medical Research Center for Therapy and Preventive Medicine · Moscow · NCT07683585

• Coronary thrombus modification to reduce microvascular damage during STEMI care

  This study tests whether modifying the clot in the heart arteries during primary PCI can lessen microvascular damage and myocardial injury in STEMI patients.

  Recruiting Odense University Hospital · Odense · NCT07646977

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.